| Literature DB >> 15635605 |
Eileen D Adamson, Jianxiu Yu, Tomas Mustelin.
Abstract
p300 and CBP are large (300 kDa) nuclear scaffold proteins that act as co-activators of transcription in most cell types and are over-expressed in prostate cancer. Recently, the Egr1 transcription factor was shown to up- or down-regulate p300 and CBP transcription based on the nature of its post-translational modification. Notably, interactions of the three proteins provide fine tuning for Egr1-induced growth or cell death responses. Copyright 2005 Wiley-Liss, Inc.Entities:
Mesh:
Substances:
Year: 2005 PMID: 15635605 DOI: 10.1002/pros.20186
Source DB: PubMed Journal: Prostate ISSN: 0270-4137 Impact factor: 4.104